Chad Vardas

Chad Vardas has a diverse work experience spanning multiple companies and roles. In 2015, they co-founded Vardas Solutions, where they served as the CEO. The company focused on developing and patenting a wrist-worn clinical-grade HRV Biofeedback treatment for anxiety and depression. Chad's role at Vardas Solutions lasted until 2021. In 2020, they also co-founded Covid Safe Zone and served as the CEO. The company developed software that could analyze heart rate variability and respiratory rate from smartphone cameras to detect changes related to COVID-19 onset. This aimed to provide universities and businesses a platform for safe in-person attendance. In the same year, Chad co-founded Aim Patents and worked as the CTO. Aim Patents specialized in building high-value patent portfolios, particularly in medical devices, software applications, energy solutions, supply chain processes, and manufacturing. Lastly, Chad's most recent position is at Vistim Labs, where they serve as the Head of Product. The company's mission is to deliver effective diagnostics for neurodegenerative diseases, enabling patients to receive timely treatment and doctors to monitor therapeutic efficacy faster.

Chad Vardas attended San Diego State University from 2016 to 2020. During this time, they pursued a Finance major and a Neuroscience minor.